Skip to content
OpenCapital
Get started

Evolus EOLS EPS (Diluted)

EPS (Diluted) at other companies

AbbVie logo
AbbVieABBV
$0.39-45.8%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×—
Current ratio2×-0.3×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's EPS (diluted)?
Evolus (EOLS) reported EPS (diluted) of -$0.16 in Q1 2026.
How has Evolus's EPS (diluted) changed year-over-year?
Evolus's EPS (diluted) increased by 46.7% year-over-year, from -$0.30 to -$0.16.
What is the long-term trend for Evolus's EPS (diluted)?
Over 4 years (2021 to 2025), Evolus's EPS (diluted) has grown at a -0.9% compound annual growth rate (CAGR), from -$0.84 to -$0.81.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.